Telemedicine support for older adults with cancer
Part of Blood & lymphatic, Cancer clinical trials.
This study uses telemedicine (video or phone visits) to help older adults with cancer, especially those in underserved communities, get better care. If you're 65 or older and starting a new cancer treatment, you may be able to join from home in English, Spanish, or Chinese.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older.
- You have been diagnosed with cancer (any stage, from I to IV).
- You are about to start a new cancer treatment (like chemotherapy, immunotherapy, or targeted therapy).
- You can read English, Spanish, or Chinese.
- Your doctor agrees that you can take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study interviews patients, caregivers, and clinicians to learn what older adults need before starting cancer treatments like chemotherapy or immunotherapy. The goal is to improve care and support for patients aged 65 and older.
This study tests whether a structured health education and “older adult care” approach—done with your oncology team—can improve support for people after cancer. It includes older cancer survivors and a chosen caregiver, using in-person or video visits for follow-up.
This study tests an educational program to help patients with advanced cancer talk about their goals of care. The goal is to make sure your wishes are known and respected by your care team.
This study tests a web-based toolkit designed to help older cancer survivors living in rural areas manage emotional distress and anxiety. It also includes a caregiver who will participate alongside the survivor.
This trial tests whether a special geriatric assessment (a check-up for older adults) and extra support can help people aged 60+ with head and neck cancer feel better during chemotherapy and radiation. It also looks at how this helps their family or friend caregivers.
This study tests whether extra geriatric support before and after CAR-T cell therapy helps people 60 and older recover faster. It is for patients with B-cell non-Hodgkin lymphoma or multiple myeloma who are scheduled for an FDA-approved CAR-T treatment.
Hear when a new Hematopoietic and Lymphoid System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.